| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/PD.4697 |
| P698 | PubMed publication ID | 26411372 |
| P50 | author | Lidewij Henneman | Q46004972 |
| Martina C. Cornel | Q59206152 | ||
| P2093 | author name string | Eva Pajkrt | |
| Wybo J Dondorp | |||
| Merel van Maarle | |||
| Saskia Tamminga | |||
| Caterina M Bilardo | |||
| Rachèl V van Schendel | |||
| Wieke Rommers | |||
| P2860 | cites work | Non-invasive prenatal testing: a review of international implementation and challenges | Q26999426 |
| Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial | Q30651815 | ||
| The quality of maternity care services as experienced by women in the Netherlands | Q33441979 | ||
| Increased nuchal translucency in euploid fetuses--what should we be telling the parents? | Q34020874 | ||
| Prenatal screening for congenital anomalies: exploring midwives' perceptions of counseling clients with religious backgrounds | Q34468736 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| Noninvasive whole-genome sequencing of a human fetus. | Q36048523 | ||
| The scope of prenatal diagnosis for women at increased risk for aneuploidies: views and preferences of professionals and potential users | Q36511337 | ||
| Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma | Q38087410 | ||
| ACMG statement on noninvasive prenatal screening for fetal aneuploidy. | Q38096182 | ||
| Prenatal screening: an ethical agenda for the near future | Q39072580 | ||
| Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing | Q39316545 | ||
| Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. | Q41235376 | ||
| Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice | Q43469221 | ||
| Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009. | Q46013175 | ||
| Cell-free DNA analysis for noninvasive examination of trisomy | Q46784231 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Non-invasive prenatal diagnosis for aneuploidy: toward an integral ethical assessment. | Q48612533 | ||
| NIPT-based screening for Down syndrome and beyond: what do pregnant women think? | Q50596773 | ||
| Current controversies in prenatal diagnosis 1: NIPT for chromosome abnormalities should be offered to women with low a priori risk. | Q51265143 | ||
| The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues. | Q53247850 | ||
| Women's and healthcare professionals' preferences for prenatal testing: a discrete choice experiment. | Q53621688 | ||
| Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals | Q56780865 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening | Q57839565 | ||
| Women’s and health professionals’ preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests | Q57839583 | ||
| P433 | issue | 13 | |
| P304 | page(s) | 1316-1323 | |
| P577 | publication date | 2015-09-28 | |
| P1433 | published in | Prenatal Diagnosis | Q15760059 |
| P1476 | title | Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals | |
| P478 | volume | 35 |
| Q48280857 | Amniocentesis is still the best option for advanced genomic testing in case of fetal malformations |
| Q42278993 | Implementing non-invasive prenatal testing into publicly funded antenatal screening services for Down syndrome and other conditions in Aotearoa New Zealand. |
| Q57809529 | Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals |
| Q38838610 | Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study. |
| Q50093623 | Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPS: results of the TRIDENT study |
| Q39487915 | Survey of attitudes of Chinese perinatologists and obstetricians toward non-invasive prenatal genetic testing |
| Q87298407 | The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice |
| Q37557986 | Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives |
| Q48169164 | Views of the obstetric profession on non-invasive prenatal testing in Aotearoa New Zealand: A national survey |
| Q33634130 | What Do Parents of Children with Down Syndrome Think about Non-Invasive Prenatal Testing (NIPT)? |
| Q47130129 | Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results. |
Search more.